Balance Sheet
Cash Flow Statement
Beginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

UNITED THERAPEUTICS (UTHR) Cash from Financing Activities: 2009-2024

Historic Cash from Financing Activities for UNITED THERAPEUTICS (UTHR) over the last 16 years, with Dec 2024 value amounting to -$1.3 billion.

  • UNITED THERAPEUTICS's Cash from Financing Activities fell 1391.42% to -$956.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.3 billion, marking a year-over-year decrease of 3.94%. This contributed to the annual value of -$1.3 billion for FY2024, which is 10444.54% down from last year.
  • According to the latest figures from FY2024, UNITED THERAPEUTICS's Cash from Financing Activities is -$1.3 billion, which was down 10,444.54% from -$11.9 million recorded in FY2023.
  • In the past 5 years, UNITED THERAPEUTICS's Cash from Financing Activities ranged from a high of $75.4 million in FY2022 and a low of -$1.3 billion during FY2024.
  • For the 3-year period, UNITED THERAPEUTICS's Cash from Financing Activities averaged around -$397.1 million, with its median value being -$11.9 million (2023).
  • In the last 5 years, UNITED THERAPEUTICS's Cash from Financing Activities skyrocketed by 365.09% in 2021 and then slumped by 10,444.54% in 2024.
  • Over the past 5 years, UNITED THERAPEUTICS's Cash from Financing Activities (Yearly) stood at -$16.9 million in 2020, then spiked by 365.09% to $44.8 million in 2021, then spiked by 68.30% to $75.4 million in 2022, then slumped by 115.78% to -$11.9 million in 2023, then tumbled by 10,444.54% to -$1.3 billion in 2024.